Ricardo SIlva - Diagnsticos Private and Hospitals Businesses Officer
| DASA3 Stock | BRL 1.99 0.09 4.74% |
Executive
Mr. Ricardo Mello de Souza e SIlva serves as Private and Hospitals Businesses Officer at Diagnosticos da America S.A. He joined the company in 2009, as Regional of Rio de Janeiro Officer. In March, 2013 he toke the role of National Commercial Officer and in May 2015 was elected Private and Hospitals Businesses Officer. Before join DASA, he worked as Commercial Superintendent of Itau Unibanco. He was National Sales Manager at GE Healthcare and Executive Manager at Unibanco. He graduated in Computer Science from Universidade Federal do Rio Grande do Sul .
| Age | 40 |
| Phone | 55 11 4197 5500 |
| Web | https://www.dasa3.com.br |
Diagnsticos Management Efficiency
The company has return on total asset (ROA) of 0.0224 % which means that it generated a profit of $0.0224 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0458) %, meaning that it generated substantial loss on money invested by shareholders. Diagnsticos' management efficiency ratios could be used to measure how well Diagnsticos manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 8 records | EXECUTIVE Age | ||
| Gustavo Estrella | CPFL Energia SA | 49 | |
| Luis Pinto | CPFL Energia SA | 62 | |
| Jose Pacheco | Odontoprev SA | 58 | |
| Eduardo Camargo | CCR SA | 49 | |
| Rose Gabay | Odontoprev SA | 55 | |
| Luis Blanco | Odontoprev SA | 45 | |
| Jose Benozatti | Odontoprev SA | 66 | |
| Karin Luchesi | CPFL Energia SA | 46 | |
Management Performance
| Return On Equity | -0.0458 | |||
| Return On Asset | 0.0224 |
Diagnsticos da Amrica Leadership Team
Elected by the shareholders, the Diagnsticos' board of directors comprises two types of representatives: Diagnsticos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diagnsticos. The board's role is to monitor Diagnsticos' management team and ensure that shareholders' interests are well served. Diagnsticos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diagnsticos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ricardo Orlando, Chief Information Technology | ||
| Octavio Silva, Member of the Executive Board, Vice President of Operations | ||
| Pedro Bueno, Chief Executive Officer, Director | ||
| Ricardo SIlva, Private and Hospitals Businesses Officer | ||
| Emerson Gasparetto, Radiology and Graphic Methods Officer, Member of the Executive Board | ||
| Carlos Neto, Chief Director | ||
| Linaldo Junior, Chief Officer | ||
| Adriano Lima, Executive Vice President of Human Resources | ||
| Fbio Cunha, Chief Officer | ||
| Felipe Guimaraes, Chief Officer |
Diagnsticos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Diagnsticos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0458 | |||
| Return On Asset | 0.0224 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 17.24 B | |||
| Shares Outstanding | 557.11 M | |||
| Shares Owned By Insiders | 56.27 % | |||
| Shares Owned By Institutions | 33.62 % | |||
| Price To Earning | 63.21 X | |||
| Price To Book | 1.00 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Diagnsticos Stock Analysis
When running Diagnsticos' price analysis, check to measure Diagnsticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnsticos is operating at the current time. Most of Diagnsticos' value examination focuses on studying past and present price action to predict the probability of Diagnsticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnsticos' price. Additionally, you may evaluate how the addition of Diagnsticos to your portfolios can decrease your overall portfolio volatility.